Additional consensus recommendations for conducting complex innovative trials of oncology agents: a post-pandemic perspective

Experimental Cancer Medicine Centres (ECMC) CID trials working group, Sarah P. Blagden, Ly-Mee Yu, Stephanie Ellis, Helen Hughes, Abeer Shaaban, Jonathan Fennelly-Barnwell, Mark P. Lythgoe, Alison M. Cooper, Francois M. Maignen, Sean W. Buckland, Pamela R. Kearns, Louise C. Brown